Back to search
FDAFDA · Food and drugs·Recall number D-1430-2015

Dexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsules. Manufactured by Alkermes Gainesville LLC Gainesville, GA 30504 for Sandoz Inc. Princeton, NJ 08540

Published September 23, 2015 · Recall initiated: July 28, 2015

Summary

FDA records drug Class III recall D-1430-2015, published September 23, 2015 and initiated July 28, 2015. Recalling firm: Novartis Pharmaceuticals Corp.; Status: Terminated; Reported quantity: 10,767 bottles; Lot: Lot #: F0002, Exp 12/2016. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novartis Pharmaceuticals Corp.
Distributor
NJ - site for distributor
Lot
Lot #: F0002, Exp 12/2016
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsules. Manufactured by Alkermes Gainesville LLC Gainesville, GA 30504 for Sandoz Inc. Princeton, NJ 08540 recalled?

Yes. FDA published recall D-1430-2015 on September 23, 2015. Reported hazard: Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter